World's Best Scientists 2026 revealed!
Jeffrey M. Isner

Jeffrey M. Isner

D-Index & Metrics

Medicine

D-Index
144
Citations
100945
World Ranking
1416
National Ranking
825

Overview

Jeffrey M. Isner was affiliated with Tufts University in the United States. Their research contributions predominantly spanned the field of Medicine, with focused work in subfields such as Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Hematology, Pulmonary and Respiratory Medicine, and Epidemiology.

The scientist's work addressed several medical topics, including Iron Metabolism and Disorders, Pericarditis and Cardiac Tamponade, Cardiac Valve Diseases and Treatments, Medical Imaging and Pathology Studies, Infective Endocarditis Diagnosis and Management, Cancer Cells and Metastasis, and Radiopharmaceutical Chemistry and Applications.

Their recent published work included one paper from 2024 titled "668 FS222 is a CD137/PD-L1 tetravalent, bispecific antibody which elicits robust pharmacodynamic activity in advanced solid tumor patients in a FIH study", which appeared in the venue Regular and Young Investigator Award Abstracts.

Throughout their career, Jeffrey M. Isner frequently collaborated with coauthors such as William C. Roberts (3 publications), Arthur Bracey (2 publications), Charles A. Hufnagel (2 publications), David J. Cutler (1 publication), and Peter W. Conrad (1 publication).

Their publication record was concentrated mainly in the venue Regular and Young Investigator Award Abstracts.

Best Publications

  • Isolation of putative progenitor endothelial cells for angiogenesis.

    Takayuki Asahara;Toyoaki Murohara;Alison Sullivan;Marcy Silver

  • Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization

    Takayuki Asahara;Haruchika Masuda;Tomono Takahashi;Christoph Kalka

  • Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.

    Tomono Takahashi;Christoph Kalka;Haruchika Masuda;Donghui Chen

  • Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

    Christoph Kalka;Haruchika Masuda;Tomono Takahashi;Wiltrud M. Kalka-Moll

  • VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells

    Takayuki Asahara;Tomono Takahashi;Haruchika Masuda;Christoph Kalka

  • THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED ENDOTHELIAL PROGENITOR CELLS FOR MYOCARDIAL ISCHEMIA

    Atsuhiko Kawamoto;Heon-Cheol Gwon;Hideki Iwaguro;Jun-Ichi Yamaguchi

  • Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.

    Satoshi Takeshita;Lu P. Zheng;Edi Brogi;Marianne Kearney

  • Constitutive Expression of phVEGF165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia

    Iris Baumgartner;Ann Pieczek;Orit Manor;Richard Blair

  • Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization

    Jun-ichi Yamaguchi;Kengo Fukushima Kusano;Osamu Masuo;Atsuhiko Kawamoto

  • Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

    T Murohara;T Asahara;M Silver;C Bauters

  • Statin Therapy Accelerates Reendothelialization A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

    Dirk H. Walter;Kilian Rittig;Ferdinand H. Bahlmann;Rudolf Kirchmair

  • Gene Therapy for Myocardial Angiogenesis : Initial Clinical Results With Direct Myocardial Injection of phVEGF165 as Sole Therapy for Myocardial Ischemia

    Douglas W. Losordo;Peter R. Vale;James F. Symes;Cheryl H. Dunnington

  • Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

    Jeffrey M Isner;Ann Pieczek;Robert Schainfeld;Richard Blair

  • Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

    Jeffrey M. Isner;Takayuki Asahara

  • Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization

    Takayuki Asahara;Donghui Chen;Tomono Takahashi;Koshi Fujikawa

  • Apoptosis in Human Atherosclerosis and Restenosis

    Jeffrey M. Isner;Marianne Kearney;Scott Bortman;Jonathan Passeri

  • HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells

    Joan Llevadot;Satoshi Murasawa;Yasuko Kureishi;Shigeki Uchida

  • Age-Dependent Impairment of Angiogenesis

    Alain Rivard;Jean-Etienne Fabre;Marcy Silver;Dongfen Chen

  • Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia

    Atsuhiko Kawamoto;Tengis Tkebuchava;Jun Ichi Yamaguchi;Hiromi Nishimura

  • Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings.

    Ernest N. Arnett;Jeffrey M. Isner;David R. Redwood;Kenneth M. Kent

Frequent Co-Authors

Douglas W. Losordo
Douglas W. Losordo Northwestern University
Takayuki Asahara
Takayuki Asahara Tokai University
Marvin A. Konstam
Marvin A. Konstam Tufts Medical Center
William C. Roberts
William C. Roberts Baylor University Medical Center
Kenneth Walsh
Kenneth Walsh University of Virginia
Napoleone Ferrara
Napoleone Ferrara University of California, San Diego
Toyoaki Murohara
Toyoaki Murohara Nagoya University
Allan H. Ropper
Allan H. Ropper Brigham and Women's Hospital
Natesa G. Pandian
Natesa G. Pandian Tufts Medical Center
Vicente Andrés
Vicente Andrés Spanish National Centre for Cardiovascular Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA isn’t limited to earning a traditional MD. Many students are turning to nursing school online for more flexibility and affordability. These programs allow students to balance study with work or family commitments while progressing toward rewarding careers in healthcare.

For those already in nursing who want to advance their expertise, an online phd in nursing offers an excellent pathway. Doctoral programs can open doors to research, academic, and leadership roles.

Registered nurses seeking to boost their qualifications often look for what is the cheapest rn to bsn program online. These RN to BSN options are designed to be both affordable and convenient, helping nurses build on their existing skills quickly.

If you hold a non-nursing bachelor’s degree but are interested in entering the field, accelerated programs such as the non nursing bachelor's to msn online provide a fast-track route into nursing practice at a graduate level. These alternative pathways highlight the diversity and accessibility of healthcare careers today.

Best Scientists Citing Jeffrey M. Isner

Recently Published Articles